Cipla: Subsidiary receives USFDA nod for Ambrisentan tablets Cipla: Subsidiary receives USFDA nod for Ambrisentan tablets DSIJ Intelligence / Tuesday, April 30, 2019 0 1127 Article rating: 5.0 Cipla with its subsidiary, Cipla USA has received approval for ANDA for Ambrisentan Tablets from the US drug regulator. The shares of the company were trading in red in the morning session. Read more
Yes Bank down 25 per cent on weak Q4 results Yes Bank down 25 per cent on weak Q4 results DSIJ Intelligence / Tuesday, April 30, 2019 0 2553 Article rating: 5.0 Leading private banker Yes Bank's shares tumbled on Tuesday as the bank posted a loss of Rs. 1,507 crore for the March quarter. In the early morning session on Tuesday, the stock was down by more than 25 per cent at Rs. 177.90 per share. Read more
Glenmark launches anti-diabetes drug Remogliflozin in India Glenmark launches anti-diabetes drug Remogliflozin in India Advait Dharmadhikari / Tuesday, April 30, 2019 0 3026 Article rating: 5.0 Glenmark announced the launch of its patent-protected and globally-researched sodium glucose co-transporter-2 (SGLT2) inhibitor Remogliflozin etabonate in India. The drug is indicated in the treatment of type-2 diabetes mellitus in adults. Read more
Five stocks with selling interest Five stocks with selling interest Shital Jibhe / Tuesday, April 30, 2019 0 1037 Article rating: 3.5 Overall volumes in futures & options currently stand at 1.10 crore contracts with a turnover of Rs. 7,32,837.82 crore. Read more
Five stocks with buying interest Five stocks with buying interest Shital Jibhe / Tuesday, April 30, 2019 0 1266 Article rating: 5.0 Overall volumes in futures & options currently stand at 1.10 crore contracts with a turnover of Rs. 7,32,837.82 crore. Read more